Tornier reported first quarter financial results, with revenue relatively flat.
Here are 10 things to know from the financial report:
1. The first quarter revenue was $88.1 million, a 1 percent decrease over the same period last year.
2. Tornier's 2015 extremities revenue was $74.8 million, up 3.9 percent over the same period last year. The Aequalis Ascend family of shoulder joint replacement products drove growth.
3. The foreign currency exchange rate negatively impacted the first quarter revenue of this year.
4. The lower extremities joints and trauma category revenue decreased 4.7 percent to $13.9 million.
5. The company's total ankle arthroplasty system revenue growth was offset by lower core foot fixation sales growth.
6. The company is merging with Wright Medical, which had an impact on the results in all segments of the lower extremities business.
7. Sports medicine and biologics product revenue decreased 3.9 percent to $3.5 million in the first quarter, reflecting a decline in soft tissue anchor and biologics products.
8. International revenue decreased 10.1 percent as reported while revenue in the United States increased 6 percent and represented 60 percent of reported global revenue.
9. Tornier is increasing the bottom end of its full year constant currency guidance for extremities, with revenue expected at $304 million to $312 million, representing 6 percent to 8.8 percent growth over the same period last year.
10. The upper extremities market is expected to primarily drive revenue growth.